
### [NCIT:C4769](http://purl.obolibrary.org/obo/NCIT_C4769)
**Label:** Malignant Pituitary Gland Neoplasm

**Subclasses:** [NCIT:C5965](http://purl.obolibrary.org/obo/NCIT_C5965) (TSH-Producing Pituitary Gland Carcinoma), [NCIT:C4536](http://purl.obolibrary.org/obo/NCIT_C4536) (Pituitary Gland Carcinoma), [NCIT:C5962](http://purl.obolibrary.org/obo/NCIT_C5962) (Prolactin-Producing Pituitary Gland Carcinoma), [NCIT:C5963](http://purl.obolibrary.org/obo/NCIT_C5963) (Growth Hormone-Producing Pituitary Gland Carcinoma), [NCIT:C5964](http://purl.obolibrary.org/obo/NCIT_C5964) (ACTH-Producing Pituitary Gland Carcinoma), [NCIT:C6805](http://purl.obolibrary.org/obo/NCIT_C6805) (Metastatic Malignant Neoplasm in the Pituitary Gland), 

**Class expressions from DL-Learner:**

- [UBERON:0003689](http://purl.obolibrary.org/obo/UBERON_0003689) (sella turcica) 57.14%
- [UBERON:0002517](http://purl.obolibrary.org/obo/UBERON_0002517) (basicranium) 57.14%
- [UBERON:0002240](http://purl.obolibrary.org/obo/UBERON_0002240) (spinal cord) 57.14%
- [UBERON:0000955](http://purl.obolibrary.org/obo/UBERON_0000955) (brain) 57.14%
- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 57.14%
- [NCIT:C12512](http://purl.obolibrary.org/obo/NCIT_C12512) (Supratentorial Brain) 57.14%
- Thing 52.12%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 39.11%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 38.90%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 38.89%
- [UBERON:0005174](http://purl.obolibrary.org/obo/UBERON_0005174) (dorsal region element) 32.14%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 31.92%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 31.80%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 31.61%
- [UBERON:0002308](http://purl.obolibrary.org/obo/UBERON_0002308) (nucleus of brain) 24.82%


